ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
0.4550
+0.0310 (7.31%)
At close: Sep 17, 2025, 4:00 PM EDT
0.4538
-0.0012 (-0.26%)
Pre-market: Sep 18, 2025, 4:16 AM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $23.57 million as of September 17, 2025. Its market cap has decreased by -42.27% in one year.
Market Cap
23.57M
Enterprise Value
19.03M
1-Year Change
-42.27%
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $23.57M, an increase of 8.02%. That is a compound annual growth rate of 0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 23.57M | -23.92% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | 24.02M | -34.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |